1-9 of 9
Ekaterina Yu. Chelysheva, MD, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Role of BCR-ABL Levels Fluctuations and Loss of Deep Molecular Response after Treatment Discontinuation in Patients with Chronic Myeloid Leukemia in the Prospective Trial RU-SKI

Anna Petrova, MD, Ekaterina Yu. Chelysheva, MD PhD, Oleg A. Shukhov, MD PhD, Anastasiya Bykova, MD, Irina Nemchenko, MD PhD, Olga Pospelova, MD, Margarita Gurianova, MD, Nikolay Tsyba, MD PhD, Tatiana I. Ionova, Prof., Anna G. Turkina, Prof., MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 30–31.
https://doi.org/10.1182/blood-2020-141798
Published: 2020
Journal Articles

PF-114: A 4 th Generation Tyrosine Kinase-Inhibitor for Chronic Phase Chronic Myeloid Leukaemia Including BCRABL1 T315I

Anna G. Turkina, Prof., MD, Olga Vinogradova, MD PhD, Elza Lomaia, MD PhD, Evgeniya Shatokhina, MD PhD, Oleg A. Shukhov, MD PhD, Ekaterina Yu. Chelysheva, MD PhD, Dzhariyat Shikhbabaeva, Irina Nemchenko, MD PhD, Anna Petrova, MD, Anastasiya Bykova, MD, Andrey Zaritskey, MD PhD, Nadia Siordia, MD, Vasily Shuvaev, MD, Jorge E. Cortes, MD, Robert Peter Gale, Michele Baccarani, MD, Oliver Ottmann, Prof, MD, Ilya Mikhailov, Fedor Novikov, PhD, Veronika Shulgina, PhD MD, Ghermes Chilov, PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1638.
https://doi.org/10.1182/blood-2019-127951
Published: 2019
Journal Articles

The Impact of Comorbidity on Quality of Life in Chronic Myeloid Leukemia Patients with Deep Molecular Response Who Stopped Therapy By Tyrosine Kinase Inhibitors: Results of the RU-SKI Trial

Tatyana Ionova, PhD Professor, Tatiana Nikitina, PhD, Natalia Porfirieva, Anna Petrova, MD, Ekaterina Yu. Chelysheva, MD PhD, Oleg A. Shukhov, MD PhD, Anastasiya Bykova, MD, Galina Gusarova, MD PhD, Irina Nemchenko, MD PhD, Nikolay Tsyba, MD PhD, Anna G. Turkina, Prof., MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2925.
https://doi.org/10.1182/blood-2019-122041
Published: 2019
Journal Articles

Changes in the Multipotent Stromal Mesenchymal Cells from the Bone Marrow of the Patients with Hematological Diseases in Debut and after the Treatment

Irina N. Shipounova, PhD, Nataliya A. Petinati, MD PhD, Nina J. Drize, PhD, Aminat A. Magomedova, MD PhD, Ekaterina A. Fastova, MD, Sergey K. Kravchenko, MD PhD, Ekaterina Yu. Chelysheva, MD PhD, Oleg A. Shukhov, MD PhD, Anna G. Turkina, Prof., MD, Elena N. Parovichnikova, MD PhD, Valery G. Savchenko, MD PhD academician
Journal: Blood
Blood (2019) 134 (Supplement_1): 5014.
https://doi.org/10.1182/blood-2019-123396
Published: 2019
Journal Articles

Pregnancy Management in CML Patients: To Treat or Not to Treat? Report of 224 Outcomes of the European Leukemia Net (ELN) Database

Elisabetta Abruzzese, MD, Anna G. Turkina, Prof., MD, Jane F. Apperley, MD FRCP, FRCPath, MB, Francesco Bondanini, MD, Paolo de Fabritiis, MD, Dong-Wook Kim, Iryna Dyagil, MD PhD, Penka Ganeva, Valentín Garcia-Gutiérrez, MD PhD, Khamida Kazakbaeva, MD, Hana Klamová, MD PhD, Konstantin Kotlyarchuk, Michael J. Mauro, MD, Dragana Milojkovic, MBBS, MD, Beatriz Moriaghi, MD, Karen Meliktesyan, MD, Franck E Nicolini, MD PhD, Evgenia Polushkina, Delphine Rea, MD, Philippe Rousselot, MD PhD, Adi Shacham, MD, Roman Shmakov, MD PhD, Malgorzata Monika Trawinska, MD, Ekaterina Yu. Chelysheva, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 498.
https://doi.org/10.1182/blood-2019-124430
Published: 2019
Journal Articles

On a Long Way to the Treatment Free Remisson: The Results of the Long-Term Observation of the Chronic Myeloid Leukemia Patients in Russian Part of EUTOS Population-Based Study

Olga V. Lazareva, PhD, Ekaterina Yu. Chelysheva, MD PhD, Anton Kulikovsky, Olga Senderova, Valentina Pepeliaeva, Sergey Meresiy, Alexander S. Luchinin, MD, Galina Milutina, Lubov Gavrilova, Ludmila Avdeeva, Dolgorzhap Dasheeva, Olga Vinogradova, MD PhD, Sergei M. Kulikov, PhD, Anna G. Turkina, Prof., MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5902.
https://doi.org/10.1182/blood-2019-131430
Published: 2019
Journal Articles

Challenge to Use the Interval Censorship Estimators for Time to Response Evaluation By Data from Chronic Myeloid Leukemia Registry

Sergey M. Kulikov, PhD, Irina A. Tischenko, Ekaterina Yu. Chelysheva, MD PhD, Olga V. Lazareva, PhD, Anna G. Turkina, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3140.
https://doi.org/10.1182/blood.V124.21.3140.3140
Published: 2014
Journal Articles

Treatment Cessation in Chronic Myeloid Leukemia As a Part of Treatment Process: Toxicity Determined and Active Stop of Tyrosine Kinase Inhibitors

Anna G. Turkina, MD PhD, Ekaterina Yu. Chelysheva, MD PhD, Vasiliy Shuvaev, Galina Gusarova, MD PhD, Anastasia Bykova, MD, Olga V. Lazareva, PhD, Oleg Shukhov, MD, Adham Abdullaev, MD PhD, Irina Martynkevich, Kudrat Abdulkadyrov, MD
Journal: Blood
Blood (2014) 124 (21): 5518.
https://doi.org/10.1182/blood.V124.21.5518.5518
Published: 2014
Journal Articles

Long-Term Results and Adverse Events Of Second Line Nilotinib Therapy After Imatinib Failure In Patients With Chronic Myeloid Leukemia In Chronic Phase In Clinical Practice

Anastasia Bykova, MD, Galina Gusarova, MD, PhD, Ekaterina Yu. Chelysheva, MD, PhD, Anna G. Turkina, MD, PhD,
Journal: Blood
Blood (2013) 122 (21): 5181.
https://doi.org/10.1182/blood.V122.21.5181.5181
Published: 2013